HEMOSTASIS IN PATIENTS WITH MULTIPLE MYELOMA BEFORE AND DURING HIGH-DOSE CHEMOTHERAPY.

被引：0
|
作者：
Urnova, E. [1 ]
Pokrovskaya, O. [1 ]
Mendeleeva, L. [1 ]
Gracheva, M. [3 ]
Balandina, A. [3 ]
Vasiliev, S. [4 ]
Ataullakhanov, F. [3 ]
Savchenko, V. [2 ]
机构：
[1] Natl Res Ctr Hematol, Dept High Dose Chemotherapy Paraproteinem Hemobla, Moscow, Russia
[2] Natl Res Ctr Hematol, Bone Marrow Transplant Dept, Moscow, Russia
[3] Natl Res Ctr Hematol, Lab Phys Biochem, Moscow, Russia
[4] Natl Res Ctr Hematol, Lab Clin Coagulol, Moscow, Russia
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1537
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [31] Survival of patients with multiple myeloma who are potential candidates for early intensification with high-dose therapy. Long-term results with conventional chemotherapy.
    Blade, J
    SanMiguel, JF
    Fontanillas, M
    BLOOD, 1995, 86 (10) : 1752 - 1752
  • [32] High-dose sequential chemotherapy in the treatment of myeloma
    Canales, M
    Ojeda, E
    Alvárez, MT
    Jiménez, V
    Jiménez, MT
    Hernández, D
    Aguado, MJ
    Bustos, JG
    Hernández-Navarro, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 352 - 352
  • [33] Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy
    Seidel, C
    Lenhoff, S
    Brabrand, S
    Anderson, G
    Standal, T
    Lanng-Nielsen, J
    Turesson, I
    Borset, M
    Waage, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) : 672 - 676
  • [34] High-dose chemotherapy with autologous stem-cell support in multiple myeloma
    Ruckser, R
    Kier, P
    Buxhofer, V
    Kittl, E
    Tatzreiter, G
    Vedovelli, H
    Zelenka, P
    Hübl, G
    Hinterberger, W
    ACTA MEDICA AUSTRIACA, 2000, 27 : 40 - 42
  • [35] High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
    Child, JA
    Morgan, GJ
    Davies, FE
    Owen, RG
    Bell, SE
    Hawkins, K
    Brown, J
    Drayson, MT
    Selby, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19): : 1875 - 1883
  • [36] Changing concepts in multiple myeloma: from conventional chemotherapy to high-dose treatment
    Sonneveld, P
    Segeren, CM
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (01) : 9 - 18
  • [37] The efficacy and toxicity of bendamustine in recurrent multiple myeloma after high-dose chemotherapy
    Knop, Stefan
    Straka, Christian
    Haen, Michael
    Schwedes, Renate
    Hebart, Holger
    Einsele, Hermann
    HAEMATOLOGICA, 2005, 90 (09) : 1287 - +
  • [38] High-dose chemotherapy with autologous stem cell rescue in multiple myeloma.
    Mahendra, P
    Ethell, M
    Johnson, D
    Seale, J
    Bass, G
    Marcus, RE
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 297 - 297
  • [39] Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy
    Buchler, T
    Krejci, M
    Svobodnik, A
    Adam, Z
    Minarik, J
    Bacovsky, J
    Scudla, V
    Mayer, J
    Vorlicek, J
    Hajek, R
    HEMATOLOGY JOURNAL, 2005, 5 (07) : 559 - 564
  • [40] Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support
    Iversen, Per Ole
    Wisloff, Finn
    Gulbrandsen, Nina
    CLINICAL NUTRITION, 2010, 29 (04) : 488 - 491
12345